The decrease of insulin-like growth factor binding protein 3 is mainly associated with disease factors, including growth hormone deficiency, Leron syndrome, diabetes, malabsorption syndrome, etc.The reduction of insulin-like growth factor binding protein 3 is mainly related to disease factors, including growth hormone deficiency, Leron syndrome, diabetes, malabsorption syndrome and so on. The Fluorescence immunoassay IGFBP-Ⅲ POCT kit can help judge growth hormone deficiency in children.

Summary

Insulin-like growth factor binding protein 3 (insulin-like growth factor binding protein 3, IGFBP-3) is a protein secreted by the liver and other tissues, which can bind and regulate the biological activity and distribution of insulin-like growth factor (IGF). IGFBP-3 is one of the most important binding proteins in the IGF growth factor family, which can prolong the half-life of IGF and regulate its distribution in tissues. The level of IGFBP-3 is related to various physiological and pathological states such as growth and development, metabolism, bone formation and tumors. The level of IGFBP-3 is often used as an indicator of clinical diagnosis and treatment. For example, the reduction of IGFBP-3 is associated with the occurrence and development of certain types of tumors, so this Fluorescent Immunoassay IGFBP-Ⅲ POCT kit can be used for early diagnosis of tumors and treatment.

PRODUCT PARAMETER

TEST INFORMATION
Method	Microfluidic Fluorescent Immunoassay	Test	LYOFIA® IGFBP-3
Format	Cassette	Reaction Time	10min
Linearity	[0.1, 16] μg/mL	Reference Interval	IFU
Sample	WB / S / P	Certificate	CE

ORDERING
Cat. No.	LMGDI325	Applicable analyzer	LYOFIA-I, LYOFIA 8,	Kit Size	25T
Cat. No.	LAGDI325	Applicable analyzer	LYOFIA 100 (Full-Automatic)	Kit Size	25T